Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants
Public ClinicalTrials.gov record NCT03029000. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-Arm Study of the Effect of a 5-day Regimen of Tbo-Filgrastim 10 mcg/kg of Body Weight Administered Subcutaneously on Peripheral Stem Cell Mobilization in Healthy Donors
Study identification
- NCT ID
- NCT03029000
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Enrollment
- 1 participant
Conditions and interventions
Conditions
Interventions
- Tbo-filgrastim Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1, 2017
- Primary completion
- Oct 29, 2017
- Completion
- Oct 29, 2017
- Last update posted
- Dec 12, 2022
2017
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 14029 | Duarte | California | 91010 | — |
| Teva Investigational Site 14025 | La Jolla | California | 92037-1027 | — |
| Teva Investigational Site 14023 | Beech Grove | Indiana | 46107 | — |
| Teva Investigational Site 14026 | Detroit | Michigan | 48201 | — |
| Teva Investigational Site 14027 | Chapel Hill | North Carolina | 27514 | — |
| Teva Investigational Site 14030 | Cincinnati | Ohio | 45242 | — |
| Teva Investigational Site 14033 | Greenville | South Carolina | 29615 | — |
| Teva Investigational Site 14035 | Memphis | Tennessee | 38120 | — |
| Teva Investigational Site 14024 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03029000, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 12, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03029000 live on ClinicalTrials.gov.